Bicara Therapeutics BCAX Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bicara Therapeutics's cash provided by (used in) operating activity, including discontinued operation?
- Bicara Therapeutics (BCAX) reported cash provided by (used in) operating activity, including discontinued operation of -$37.51M in Q1 2026.
- How has Bicara Therapeutics's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Bicara Therapeutics's cash provided by (used in) operating activity, including discontinued operation decreased by 33.5% year-over-year, from -$28.11M to -$37.51M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.